Concepedia

Christopher Famulare

CF

32

Publications

3.8K

Citations

23

H-Index

2016

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

University of Pennsylvania

Northwestern University

Moffitt Cancer Center

Christopher Famulare is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, hematology, and cell biology.

Top concepts

MedicineHematologyCell BiologyOncologyTumor BiologyCancer ResearchMolecular DiagnosticsHealthGeneticsPathology

Publications per year

2016–2023

32

Publications

32

The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells

Ly Vu, Brian F. Pickering, Yuanming Cheng et al. · Nature Medicine · 2017 · 1.3K citations · Full text

Hematological Malignancy, Chromatin, Myeloid Differentiation +12

Single-cell mutation analysis of clonal evolution in myeloid malignancies

Linde A. Miles, Robert L. Bowman, Tiffany R. Merlinsky et al. · Nature · 2020 · 500 citations · Full text

Hematological Malignancy, Tumor Heterogeneity, Hematology +7

Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations

Andrew M. Intlekofer, Alan H. Shih, Bo Wang et al. · Nature · 2018 · 271 citations · Full text

Somatic Variant, Genetics, Dimer-interface Mutations +8

Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition

James J. Harding, Maeve A. Lowery, Alan H. Shih et al. · Cancer Discovery · 2018 · 201 citations · Full text

Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML

Maximilian Stahl, Kamal Menghrajani, Andriy Derkach et al. · Blood Advances · 2021 · 181 citations · Full text

Rows per page

1–5 of 32